LUBNA LATIF: Open Payments
NPI 1598222119 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,031 in 136 payments from 17 companies in 2025. Trend: 2023 $3,113 · 2024 $3,757 · 2025 $3,031
Food & beverage: $2,635Education: $396
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $666 |
| ABBVIE INC. | 34 | $467 |
| Incyte Corporation | 12 | $290 |
| GENZYME CORPORATION | 6 | $260 |
| E.R. Squibb & Sons, L.L.C. | 10 | $205 |
| Organon LLC | 10 | $170 |
| Regeneron Healthcare Solutions, Inc. | 3 | $158 |
| Galderma Laboratories, L.P. | 16 | $152 |
| UCB, Inc. | 4 | $126 |
| LEO Pharma Inc. | 5 | $122 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Opzelura, Sotyktu, RINVOQ, VTAMA, Bimzelx.
Industry payments across CT — which companies pay providers there.
